Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Primary Membranous Nephropathy
Clinical trial register · United States · industry-sponsored

Primary Membranous Nephropathy Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9164 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 27 Oct 2026, 03:16 UTC
9164
Studies in scope
industry-sponsored, all four open statuses
4968
Recruiting now
open to new participants
2200
Lead sponsors
across recruiting studies
Top states
California 8 Texas 6 Florida 5 New York 5 Michigan 4
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Primary Membranous Nephropathy trials in the USA

9 of 9164 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
AstraZeneca
Phase 2
43
California, Iowa, Maryland, New York, Texas
2026-03-28
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Alabama, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois
2025-09-30
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
California, Minnesota, Texas
2025-09-19
Recruiting
Climb Bio, Inc.
Phase 2
45
Colorado, Florida, Georgia, Indiana, New York, Texas
2025-08-25
Recruiting
Biogen
Phase 3
180
Alabama, California, Michigan, New York, North Carolina, Ohio, Tennessee, Texas
2025-05-22
Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
NCT06557265Lupus Nephritis, Primary Membranous Nephropathy
DrugNKX019
Nkarta, Inc.
Phase 1/2
120
Arkansas, California, Florida, Georgia, Illinois, Louisiana, Massachusetts, Michigan
2024-06-13
Active, closed
BeOne Medicines
Phase 2/3
178
California, Minnesota, Nevada
2023-04-17
Recruiting
Cerium Pharmaceuticals, Inc.
Phase 3
148
California, Florida, Georgia, Illinois, Iowa, Michigan, New York, Texas
2023-03-13
Active, closed
Hoffmann-La Roche
Phase 3
142
California, Colorado, Florida, Iowa, Michigan, Minnesota, New York, Texas
2021-06-25
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-usa/condition/primary-membranous-nephropathy

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,164 studies in total at the last sync on 27 Oct 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies listing the condition Primary Membranous Nephropathy.

How many Primary Membranous Nephropathy trials are recruiting in the US?

7 of the 9 studies on this page are recruiting new participants as of the 27 Oct 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Primary Membranous Nephropathy), 9 studies
PhaseStudiesRecruitingShare
Phase 23333.3%
Phase 33233.3%
Phase 2/32122.2%
Phase 1/21111.1%

Most active sponsors

Lead sponsors with the most studies (Primary Membranous Nephropathy)
Lead sponsorStudiesRecruiting
Alexion Pharmaceuticals, Inc.11
AstraZeneca11
BeOne Medicines10
Biogen11
Cerium Pharmaceuticals, Inc.11
Climb Bio, Inc.11
Hoffmann-La Roche10
Nkarta, Inc.11
Vertex Pharmaceuticals Incorporated11

Top states

Top states (Primary Membranous Nephropathy), by number of studies with a site there
StateStudies
California8
Texas6
Florida5
New York5
Georgia4
Michigan4
Colorado3
Illinois3
Iowa3
Minnesota3
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.